Top Markets
Coin of the day
Mural Oncology plc Mural Oncology plc

Mural Oncology plc

MURA
Classement en actions #27062
Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and... Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and advancing immune-based therapies for individuals battling cancer. Its primary drug candidate, nemvaleukin alfa, is currently under investigation as a standalone agent for mucosal melanoma and in partnership with pembrolizumab for platinum-resistant ovarian cancer. Additionally, the company is progressing projects centered on modified interleukin-18 and tumor-specific interleukin-12. Incorporated in 2017, Mural Oncology maintains its headquarters in Dublin, Ireland. By November 15, 2023, the company had transitioned from being a subsidiary of Alkermes plc.
Prix de l'action
$2.04
Dernière synchronisation: 2025-12-09
Capitalisation boursière
$35.38M
Changement (1 jour)
0.00%
Changement (1 an)
-2.39%
Pays
IE
Échange Mural Oncology plc (MURA)

Catégorie

Ratio P/S pour Mural Oncology plc (MURA)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Mural Oncology plc, le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Mural Oncology plc de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
10.17 -
US
11.28 -
US
10.13 -
NL
2.95 -
AU
- -
CH